UBS Life Sciences Conference 2005 - Pall Corporation (PLL)

More documents

Recommendations

Info

New <strong>Pall</strong> BioPharmaceuticals Products For A Rapidly Growing Market 28
<strong>Pall</strong> Emerges as a Key Player in Chromatography • The chromatography market is estimated at 40% of the total biotech industry spend • Chromatography resins are typically replaced once a year 29
Page 1 and 2: UBS Global Life Sciences Conference
Page 3 and 4: Agenda • Overview of our Business
Page 5 and 6: A Strong Annuity Business 75% of ou
Page 7 and 8: The Growth Potential for Filtration
Page 9 and 10: We Are Realizing Our Vision • Our
Page 11 and 12: Pall Advanced Separations Systems (
Page 13 and 14: Pall Systems Help Generate Annuity
Page 15 and 16: Pall Process Technologies Markets M
Page 17 and 18: Mobile Water Systems • Deployed a
Page 19 and 20: Sustained Growth for Fuels & Chemic
Page 21 and 22: Microelectronics Positioned for Ste
Page 23 and 24: Pall Life Sciences Markets BioPharm
Page 25 and 26: Pall Leukotrap ® Affinity Prion Re
Page 27: Pall Products for Infection Control
Page 31 and 32: Marcus Wilson, President and CFO
Page 33 and 34: Outside Sales and Operating Profit
Page 35 and 36: Comparative Income Statements (Full
Page 37 and 38: Balance Sheet & Cash Flow Data ($ i
Page 39: Fiscal 2006 EPS Expectations • Sa

UBS Life Sciences Conference 2005 - Pall Corporation (PLL)

Create successful ePaper yourself

Delete template?

Save as template?